{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:48:06Z","timestamp":1793940486974,"version":"4.8.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.nuclcard.2024.102106","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T08:03:46Z","timestamp":1733904226000},"page":"102106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Cardiovascular positron emission tomography imaging of fibroblast activation: A review of the current literature"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1378-306X","authenticated-orcid":false,"given":"Krithika","family":"Loganath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2882-578X","authenticated-orcid":false,"given":"Neil","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Anagnostopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Anna","family":"Erba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8081-0641","authenticated-orcid":false,"given":"Andor W.J.M.","family":"Glaudemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Saraste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bucerius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lubberink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8478-9675","authenticated-orcid":false,"given":"Olivier","family":"Gheysens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny R.","family":"Buechel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Gaemperli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3378-1723","authenticated-orcid":false,"given":"Alessia","family":"Gimelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9600-0376","authenticated-orcid":false,"given":"Fabien","family":"Hyafil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Newby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riemer H.J.A.","family":"Slart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Dweck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nuclcard.2024.102106_bib1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09790-1","article-title":"Global fibroblast activation throughout the left ventricle but localized fibrosis after myocardial infarction","volume":"7","author":"Nagaraju","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.nuclcard.2024.102106_bib3","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1136\/heartjnl-2019-315560","article-title":"Myocardial fibrosis: why image, how to image and clinical implications","volume":"105","author":"Bing","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.nuclcard.2024.102106_bib4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jacc.2010.11.013","article-title":"Assessment of myocardial fibrosis with cardiovascular magnetic resonance","volume":"57","author":"Mewton","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib5","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1158\/1078-0432.CCR-22-1379","article-title":"Monitoring therapeutic response to anti-FAP CAR T cells using [18F]AlF-FAPI-74","volume":"28","author":"Lee","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nuclcard.2024.102106_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.797960","article-title":"FAPI PET\/CT in the diagnosis of abdominal and pelvic tumors","volume":"11","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib8","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac fibrosis","volume":"118","author":"Travers","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.nuclcard.2024.102106_bib9","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.CIR.92.5.1355","article-title":"A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association","volume":"92","author":"Stary","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2024.102106_bib10","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib11","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1161\/ATVBAHA.116.307993","article-title":"Atherosclerotic plaque rupture: identifying the straw that breaks the camel's back","volume":"36","author":"Chen","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib12","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1253\/circj.CJ-16-1003","article-title":"Defining the cardiac fibroblast","volume":"80","author":"Ivey","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.nuclcard.2024.102106_bib13","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.RES.82.10.1043","article-title":"Epicardium-derived cells contribute a novel population to the myocardial wall and the atrioventricular cushions","volume":"82","author":"Groot","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.nuclcard.2024.102106_bib14","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI74783","article-title":"Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis","volume":"124","author":"Moore-Morris","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nuclcard.2024.102106_bib15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/CIRCRESAHA.115.303794","article-title":"Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation","volume":"115","author":"Ali","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.nuclcard.2024.102106_bib16","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/hh2401.100844","article-title":"Contribution of adventitial fibroblasts to neointima formation and vascular remodeling","volume":"89","author":"Sartore","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.nuclcard.2024.102106_bib17","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1161\/01.ATV.0000247243.48542.9d","article-title":"Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice","volume":"26","author":"Bentzon","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.yjmcc.2015.11.025","article-title":"Mechanical control of cardiac myofibroblasts","volume":"93","author":"van Putten","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/biom9090472","article-title":"Fibroblasts and their pathological functions in the fibrosis of aortic valve sclerosis and atherosclerosis","volume":"9","author":"Singh","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.nuclcard.2024.102106_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111435","article-title":"Development of a stromal microenvironment experimental model containing proto-myofibroblast like cells and analysis of its crosstalk with melanoma cells: a new tool to potentiate and stabilize tumor suppressor phenotype of dermal myofibroblasts","volume":"8","author":"Avagliano","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.nuclcard.2024.102106_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrm809","article-title":"Myofibroblasts and mechano-regulation of connective tissue remodelling","volume":"3","author":"Tomasek","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib22","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1073\/pnas.91.12.5657","article-title":"Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers","volume":"91","author":"Scanlan","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nuclcard.2024.102106_bib23","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2005-08-3452","article-title":"Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein","volume":"107","author":"Lee","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.nuclcard.2024.102106_bib24","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/CIRCRESAHA.109.209809","article-title":"Cardiac fibroblast: the renaissance cell","volume":"105","author":"Souders","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.nuclcard.2024.102106_bib25","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jcmgh.2022.12.005","article-title":"Fibroblast activation protein activates macrophages and promotes parenchymal liver inflammation and fibrosis","volume":"15","author":"Yang","year":"2023","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"key":"10.1016\/j.nuclcard.2024.102106_bib26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jcmgh.2022.12.005","article-title":"Fibroblast activation protein activates macrophages and promotes parenchymal liver inflammation and fibrosis","volume":"15","author":"Yang","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib27","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00259-022-06052-9","article-title":"Current research topics in FAPI theranostics: a bibliometric analysis","volume":"50","author":"van den Hoven","year":"2023","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2024.102106_bib28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1021\/ml300410d","article-title":"Selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold","volume":"4","author":"Jansen","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.nuclcard.2024.102106_bib29","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","article-title":"Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein","volume":"59","author":"Lindner","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2967\/jnumed.120.244806","article-title":"The latest developments in imaging of fibroblast activation protein","volume":"62","author":"Altmann","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib31","article-title":"FAPI-04 PET\/CT using [18F]AlF labeling strategy: automatic synthesis, quality control, and in vivo assessment in patient","volume":"11","author":"Jiang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2967\/jnumed.120.245084","article-title":"FAPI-74 PET\/CT using either 18F-AlF or cold-kit 68Ga labeling: biodistribution, radiation dosimetry, and tumor delineation in lung cancer patients","volume":"62","author":"Giesel","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ph15080958","article-title":"Automated radiosynthesis, preliminary in vitro\/in vivo characterization of OncoFAP-based radiopharmaceuticals for cancer imaging and therapy","volume":"15","author":"Bartoli","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.nuclcard.2024.102106_bib34","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","article-title":"A tumor-imaging method targeting cancer-associated fibroblasts","volume":"59","author":"Loktev","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib35","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2967\/jnumed.120.256271","article-title":"Fapi pet\/ct: will it end the hegemony of 18F-FDG in oncology?","volume":"62","author":"Hicks","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib36","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1007\/s00259-021-05307-1","article-title":"Head-to-head intra-individual comparison of biodistribution and tumor uptake of (68)Ga-FAPI and (18)F-FDG PET\/CT in cancer patients","volume":"48","author":"Giesel","year":"2021","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2024.102106_bib37","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/annrheumdis-2020-217408","article-title":"Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging","volume":"79","author":"Schmidkonz","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.nuclcard.2024.102106_bib38","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2967\/jnumed.120.244723","article-title":"Fibroblast activation protein\u2013targeted PET\/CT with 68Ga-FAPI for imaging IgG4-related disease: comparison to 18F-FDG PET\/CT","volume":"62","author":"Luo","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib39","first-page":"190","article-title":"Clinical Value of 18F-FAPI PET\/CT in assessing early-stage fibrosis of graft after liver transplantation: preliminary experience","volume":"14","author":"Fang","year":"2022","journal-title":"Research Square"},{"key":"10.1016\/j.nuclcard.2024.102106_bib40","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1007\/s00259-021-05660-1","article-title":"[68 Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease","volume":"49","author":"Conen","year":"2022","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2024.102106_bib41","first-page":"190","article-title":"Fibroblast Activation Protein specific PET\/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study","volume":"14","author":"R\u00f6hrich","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib42","article-title":"Ga-68-FAPI as diagnostic tool in sarcoma: data from the FAPI-PET prospective observational trial","volume":"121","author":"Kessler","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib43","first-page":"727","article-title":"Initial clinical experience with (90)Y-FAPI-46 radioligand therapy for advanced-stage solid tumors: a case series of 9 patients","volume":"63","author":"Ferdinandus","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib44","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2967\/jnumed.121.262426","article-title":"Correlation of 68Ga-FAPi-46 PET biodistribution with FAP expression by immunohistochemistry in patients with solid cancers: interim analysis of a prospective translational exploratory study","volume":"63","author":"Mona","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib45","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1158\/1078-0432.CCR-22-1379","article-title":"Monitoring therapeutic response to anti-FAP CAR T cells using [18F] AlF-FAPI-74","volume":"28","author":"Lee","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nuclcard.2024.102106_bib46","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00259-020-05132-y","article-title":"Biodistribution, pharmacokinetics, dosimetry of [(68)Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [(18)F]F-FDG PET\/CT in patients with various cancers","volume":"48","author":"Ballal","year":"2021","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2024.102106_bib47","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2967\/jnumed.122.264941","article-title":"Three-time-point PET analysis of 68Ga-FAPI-46 in a variety of cancers","volume":"64","author":"Naeimi","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib48","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2967\/jnumed.118.224469","article-title":"Development of fibroblast activation protein-targeted radiotracers with improved tumor retention","volume":"60","author":"Loktev","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib49","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2967\/jnumed.119.236786","article-title":"Radiation dosimetry and biodistribution of 68Ga-FAPI-46 PET imaging in cancer patients","volume":"61","author":"Meyer","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40658-022-00487-7","article-title":"Comparison of image quality and spatial resolution between (18)F, (68)Ga, and (64)Cu phantom measurements using a digital Biograph Vision PET\/CT","volume":"9","author":"Braune","year":"2022","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.nuclcard.2024.102106_bib51","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1007\/s00259-021-05576-w","article-title":"Positron emission tomography and computed tomography with [(68)Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer","volume":"49","author":"Pang","year":"2022","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2024.102106_bib52","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1007\/s00259-021-05343-x","article-title":"Value of [(68)Ga]Ga-FAPI-04 imaging in the diagnosis of renal fibrosis","volume":"48","author":"Zhou","year":"2021","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2024.102106_bib53","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1007\/s00259-021-05378-0","article-title":"(68)Ga-FAPI-PET\/CT in patients with various gynecological malignancies","volume":"48","author":"Dendl","year":"2021","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2024.102106_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s41181-020-00112-x","article-title":"Fully-automated production of [68Ga]Ga-FAPI-46 for clinical application","volume":"5","author":"Spreckelmeyer","year":"2020","journal-title":"EJNMMI Radiopharmacy and Chemistry"},{"key":"10.1016\/j.nuclcard.2024.102106_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40336-020-00402-z","article-title":"Radiolabeled fibroblast activation protein inhibitor (FAPI) PET in oncology: has the time come for 18F-fluorodeoxyglucose to think to a well-deserved retirement?","volume":"9","author":"Guglielmo","year":"2021","journal-title":"Clinical and Translational Imaging"},{"key":"10.1016\/j.nuclcard.2024.102106_bib56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/ehjci\/jeac242","article-title":"Emerging molecular imaging targets and tools for myocardial fibrosis detection","volume":"24","author":"Barton","year":"2022","journal-title":"European Heart Journal - Cardiovascular Imaging"},{"key":"10.1016\/j.nuclcard.2024.102106_bib57","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/eurheartj\/ehz736","article-title":"Cardiac fibroblast activation detected by positron emission tomography\/computed tomography as a possible sign of cardiotoxicity","volume":"41","author":"Totzeck","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nuclcard.2024.102106_bib58","article-title":"Relationship between cardiac fibroblast activation protein activity by positron emission tomography and cardiovascular disease","volume":"13","author":"Heckmann","year":"2020","journal-title":"Circulation: Cardiovascular Imaging"},{"key":"10.1016\/j.nuclcard.2024.102106_bib59","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2967\/jnumed.119.226993","article-title":"Molecular imaging of fibroblast activity after myocardial infarction using a (68)Ga-labeled fibroblast activation protein inhibitor, FAPI-04","volume":"60","author":"Varasteh","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib60","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1021\/acs.molpharmaceut.2c00551","article-title":"Noninvasive monitoring of reparative fibrosis after myocardial infarction in rats using 68Ga-FAPI-04 PET\/CT","volume":"19","author":"Qiao","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nuclcard.2024.102106_bib61","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.121.263555","article-title":"Cardiac fibroblast activation in patients early after acute myocardial infarction: integration with MR tissue characterization and subsequent functional outcome","volume":"63","author":"Diekmann","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib62","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1007\/s00259-021-05674-9","article-title":"Fibroblast activation protein imaging in reperfused ST-elevation myocardial infarction: comparison with cardiac magnetic resonance imaging","volume":"49","author":"Xie","year":"2022","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2024.102106_bib63","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2021.02.019","article-title":"Molecular imaging identifies fibroblast activation beyond the infarct region after acute myocardial infarction","volume":"77","author":"Diekmann","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib64","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00259-022-06015-0","article-title":"[68Ga]Ga-DOTA-FAPI-04 PET\/MR in patients with acute myocardial infarction: potential role of predicting left ventricular remodeling","volume":"50","author":"Zhang","year":"2023","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2024.102106_bib65","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/RLU.0000000000003745","article-title":"Visualization of fibroblast activation after myocardial infarction using 68Ga-FAPI PET","volume":"46","author":"Kessler","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcha.2024.101340","article-title":"Delayed 68Ga-FAPI-46 PET\/MR imaging confirms ongoing fibroblast activation in patients after acute myocardial infarction","volume":"50","author":"Kupusovic","year":"2024","journal-title":"IJC Heart & Vasculature"},{"key":"10.1016\/j.nuclcard.2024.102106_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.101910","article-title":"99mTc-HFAPi SPECT imaging predicts left ventricular remodeling after acute myocardial infarction","volume":"38","author":"Hua","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib68","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00259-022-05984-6","article-title":"Molecular imaging of fibroblast activity in pressure overload heart failure using [68 Ga]Ga-FAPI-04 PET\/CT","volume":"50","author":"Wang","year":"2023","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2024.102106_bib69","first-page":"3330","article-title":"[18F]AlF-NOTA-FAPI-04 PET imaging of fibroblast activation protein in heart failure with preserved ejection fraction","volume":"63","author":"Sun","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib70","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00259-022-05994-4","article-title":"68Ga-FAPI PET visualize heart failure: from mechanism to clinic","volume":"50","author":"Song","year":"2023","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2024.102106_bib71","first-page":"1","article-title":"Early detection of anthracycline-induced cardiotoxicity using [(68) Ga]Ga-FAPI-04 imaging","author":"Wei","year":"2024","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2024.102106_bib72","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.jcmg.2022.06.004","article-title":"Feasibility of 68Ga-labeled fibroblast activation protein inhibitor PET\/CT in light-chain cardiac amyloidosis","volume":"15","author":"Wang","year":"2022","journal-title":"JACC (J Am Coll Cardiol): Cardiovascular Imaging"},{"key":"10.1016\/j.nuclcard.2024.102106_bib73","article-title":"Myocardial activity at 18F-FAPI PET\/CT and risk for sudden cardiac death in hypertrophic cardiomyopathy","volume":"306","author":"Wang","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.nuclcard.2024.102106_bib74","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13550-023-00986-3","article-title":"Molecular imaging of fibroblast activation in multiple non-ischemic cardiomyopathies","volume":"13","author":"Wang","year":"2023","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.nuclcard.2024.102106_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.614997","article-title":"Early detection of Checkpoint inhibitor-associated myocarditis using 68Ga-FAPI PET\/CT","volume":"8","author":"Finke","year":"2021","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10.1016\/j.nuclcard.2024.102106_bib76","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00259-021-05577-9","article-title":"Imaging of cardiac fibroblast activation in patients with chronic thromboembolic pulmonary hypertension","volume":"49","author":"Chen","year":"2021","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2024.102106_bib77","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12350-022-02952-3","article-title":"68Ga-FAPI PET\/CT for molecular assessment of fibroblast activation in right heart in pulmonary arterial hypertension: a single-center, pilot study","volume":"30","author":"Gu","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib78","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2967\/jnumed.122.265147","article-title":"Molecular imaging of myocardial fibroblast activation in patients with advanced aortic stenosis before transcatheter aortic valve replacement: a pilot study","volume":"64","author":"Diekmann","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib79","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1007\/s12350-021-02646-2","article-title":"Diffuse uptake of [68Ga]Ga-FAPI in the left heart in a patient with hypertensive heart disease by PET\/CT","volume":"29","author":"Lin","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.101835","article-title":"Potential application of 68Ga-FAPI PET\/CT for diagnosing cardiac sarcoidosis","volume":"36","author":"Solanki","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib81","doi-asserted-by":"crossref","DOI":"10.1093\/ehjcr\/ytac419","article-title":"Cardiac fibroblast activation in Fabry disease on 18F-fibroblast activation protein inhibitor positron emission tomography\/computed tomography imaging","volume":"6","author":"Wang","year":"2022","journal-title":"European Heart Journal - Case Reports"},{"key":"10.1016\/j.nuclcard.2024.102106_bib82","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/01.ATV.0000199393.74656.4c","article-title":"Phenotypic modulation of intima and media smooth muscle cells in fatal cases of coronary artery lesion","volume":"26","author":"Hao","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11853","article-title":"Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability","volume":"7","author":"Evrard","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.nuclcard.2024.102106_bib84","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1007\/s00259-023-06245-w","article-title":"Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors","volume":"50","author":"Kosmala","year":"2023","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2024.102106_bib85","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2967\/jnumed.121.262863","article-title":"Feasibility of in vivo imaging of fibroblast activation protein in human arterial walls","volume":"63","author":"Wu","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib86","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/RLU.0000000000003692","article-title":"68Ga-FAPI PET\/CT versus 18F-FDG PET\/CT for the evaluation of disease activity in Takayasu arteritis","volume":"46","author":"Wu","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib87","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/RLU.0000000000004793","article-title":"Serial 68Ga-FAPI PET\/CT after treatment of immunoglobulin G4-related pancreatitis and retroperitoneal fibrosis","volume":"48","author":"Cho","year":"2023","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib88","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/hrt.2003.015347","article-title":"Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease","volume":"90","author":"Boldt","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.nuclcard.2024.102106_bib89","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1161\/CIRCULATIONAHA.108.811877","article-title":"Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation","volume":"119","author":"Oakes","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2024.102106_bib90","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1007\/s12350-023-03352-x","article-title":"Fibroblast activation protein imaging in atrial fibrillation: a proof-of-concept study","volume":"30","author":"Li","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib91","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00259-021-05612-9","article-title":"Visualization of thermal damage using (68) Ga-FAPI-PET\/CT after pulmonary vein isolation","volume":"49","author":"Kupusovic","year":"2022","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2024.102106_bib92","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/heartjnl-2016-310115","article-title":"Cardiac \u03b1(V)\u03b2(3) integrin expression following acute myocardial infarction in humans","volume":"103","author":"Jenkins","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.nuclcard.2024.102106_bib93","first-page":"123","article-title":"Isomers of 4-[18F] fluoro-proline: radiosynthesis, biological evaluation and results in humans using PET","volume":"7","author":"Geisler","year":"2014","journal-title":"Curr Rad"},{"key":"10.1016\/j.nuclcard.2024.102106_bib94","first-page":"413","article-title":"Cis-4-[18F]Fluoro-<span class=\"sc\">l<\/span>-Proline PET imaging of pulmonary fibrosis in a rabbit model","volume":"43","author":"Wallace","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib95","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MNM.0000000000000982","article-title":"Cis-4-[18F]fluoro-D-proline detects neurodegeneration in patients with akinetic-rigid parkinsonism","volume":"40","author":"Sommerauer","year":"2019","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.nuclcard.2024.102106_bib96","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.118.007835","article-title":"(18)F-Fluoride signal amplification identifies microcalcifications associated with atherosclerotic plaque instability in positron emission tomography\/computed tomography images","volume":"12","author":"Creager","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102106_bib97","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.hrthm.2012.01.008","article-title":"Atrial fibrillation substrate: the \u201cunknown species\u201d\u2014from lone atrial fibrillation to fibrotic atrial cardiomyopathy","volume":"9","author":"Kottkamp","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.nuclcard.2024.102106_bib98","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/jce.12199","article-title":"Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation","volume":"24","author":"Akoum","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib99","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jacc.2010.09.049","article-title":"Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation","volume":"57","author":"Daccarett","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s12350-012-9668-9","article-title":"The role of F18-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis","volume":"20","author":"Mc Ardle","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib101","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1007\/s00259-021-05461-6","article-title":"Long axial field of view PET scanners: a road map to implementation and new possibilities","volume":"48","author":"Slart","year":"2021","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2024.102106_bib102","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jcmg.2023.06.022","article-title":"Total-body positron emission tomography: adding new perspectives to cardiovascular research","volume":"16","author":"Cherry","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102106_bib103","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11239-019-02026-1","article-title":"Tissue-level inflammation and ventricular remodeling in hypertrophic cardiomyopathy","volume":"49","author":"Becker","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.nuclcard.2024.102106_bib104","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.hrthm.2018.11.024","article-title":"Arrhythmias in myocarditis: state of the art","volume":"16","author":"Peretto","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.nuclcard.2024.102106_bib105","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/S2665-9913(20)30421-5","article-title":"68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study","volume":"3","author":"Bergmann","year":"2021","journal-title":"The Lancet Rheumatology"},{"key":"10.1016\/j.nuclcard.2024.102106_bib106","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib107","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib108","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting cardiac fibrosis with engineered T cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.nuclcard.2024.102106_bib109","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.ymthe.2019.09.021","article-title":"CARdiac immunotherapy: T cells engineered to treat the fibrotic heart","volume":"27","author":"Vagnozzi","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.nuclcard.2024.102106_bib110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.nuclcard.2024.102106_bib111","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s41181-020-00102-z","article-title":"Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators","volume":"5","author":"Moon","year":"2020","journal-title":"EJNMMI Radiopharmacy and Chemistry."},{"key":"10.1016\/j.nuclcard.2024.102106_bib112","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2967\/jnumed.119.233122","article-title":"Theranostics targeting fibroblast activation protein in the tumor stroma: (64)Cu- and (225)Ac-labeled FAPI-04 in pancreatic cancer xenograft mouse models","volume":"61","author":"Watabe","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib113","first-page":"65","article-title":"Novel fibroblast activation protein inhibitor-based targeted theranostics for radioiodine-refractory differentiated thyroid cancer patients: a pilot study","volume":"32","author":"Ballal","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.nuclcard.2024.102106_bib114","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s41181-021-00144-x","article-title":"(18)F-labeled tracers targeting fibroblast activation protein","volume":"6","author":"Lindner","year":"2021","journal-title":"EJNMMI Radiopharm Chem."},{"key":"10.1016\/j.nuclcard.2024.102106_bib115","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101852118","article-title":"An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications","volume":"118","author":"Millul","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nuclcard.2024.102106_bib116","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s00259-021-05653-0","article-title":"Translational imaging of the fibroblast activation protein (FAP) using the new ligand [(68)Ga]Ga-OncoFAP-DOTAGA","volume":"49","author":"Backhaus","year":"2022","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2024.102106_bib117","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1161\/HYPERTENSIONAHA.114.03279","article-title":"Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload\u2013induced heart failure","volume":"63","author":"Szab\u00f3","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.nuclcard.2024.102106_bib118","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.yjmcc.2015.11.003","article-title":"Connective tissue growth factor regulates cardiac function and tissue remodeling in a mouse model of dilated cardiomyopathy","volume":"89","author":"Koshman","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib119","first-page":"83","article-title":"Connective tissue growth factor inhibition enhances cardiac repair and limits fibrosis after myocardial infarction","volume":"4","author":"Vainio","year":"2019","journal-title":"JACC (J Am Coll Cardiol): Basic to Translational Science"},{"key":"10.1016\/j.nuclcard.2024.102106_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110071","article-title":"Modified citrus pectin ameliorates myocardial fibrosis and inflammation via suppressing galectin-3 and TLR4\/MyD88\/NF-\u03baB signaling pathway","volume":"126","author":"Xu","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nuclcard.2024.102106_bib121","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HYPERTENSIONAHA.115.06161","article-title":"Inhibition of galectin-3 pathway prevents isoproterenol-induced left ventricular dysfunction and fibrosis in mice","volume":"67","author":"Vergaro","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.nuclcard.2024.102106_bib122","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41467-020-14349-2","article-title":"Preclinical development of a miR-132 inhibitor for heart failure treatment","volume":"11","author":"Foinquinos","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.nuclcard.2024.102106_bib123","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehaa898","article-title":"Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study","volume":"42","author":"T\u00e4ubel","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nuclcard.2024.102106_bib124","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/aps.2014.45","article-title":"Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice","volume":"35","author":"Weng","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.nuclcard.2024.102106_bib125","doi-asserted-by":"crossref","first-page":"H512","DOI":"10.1152\/ajpheart.00137.2015","article-title":"Pirfenidone exhibits cardioprotective effects by regulating myocardial fibrosis and vascular permeability in pressure-overloaded hearts","volume":"309","author":"Yamagami","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib126","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41591-021-01452-0","article-title":"Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial","volume":"27","author":"Lewis","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.nuclcard.2024.102106_bib127","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.hrthm.2010.04.030","article-title":"Pirfenidone mitigates left ventricular fibrosis and dysfunction after myocardial infarction and reduces arrhythmias","volume":"7","author":"Nguyen","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.nuclcard.2024.102106_bib128","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.ijcard.2012.11.067","article-title":"A new anti-fibrotic drug attenuates cardiac remodeling and systolic dysfunction following experimental myocardial infarction","volume":"168","author":"Zhang","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib129","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/01.HYP.0000208840.30778.00","article-title":"Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload","volume":"47","author":"Matsusaka","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.nuclcard.2024.102106_bib130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacc.2006.02.055","article-title":"Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction","volume":"48","author":"Hudson","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102106_bib131","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCRESAHA.111.300502","article-title":"Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation","volume":"112","author":"Ma","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.nuclcard.2024.102106_bib132","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/labinvest.2010.198","article-title":"Relaxin remodels fibrotic healing following myocardial infarction","volume":"91","author":"Samuel","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.nuclcard.2024.102106_bib133","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.nuclcard.2024.102106_bib134","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1210\/en.2007-1220","article-title":"Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis","volume":"149","author":"Xu","year":"2008","journal-title":"Endocrinol"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358124008080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358124008080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T11:59:43Z","timestamp":1748001583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358124008080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":134,"alternative-id":["S1071358124008080"],"URL":"https:\/\/doi.org\/10.1016\/j.nuclcard.2024.102106","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular positron emission tomography imaging of fibroblast activation: A review of the current literature","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nuclcard.2024.102106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society of Nuclear Cardiology.","name":"copyright","label":"Copyright"}],"article-number":"102106"}}